Press Releases

Date	Title	Company
22-Dec-2020	Canine Arthritis Treatment Market Analysis, Growth by Top Companies, Trends by Application, Forecast – 2029	MARKITWIRED
22-Dec-2020	FDA Warns Companies Illegally Selling CBD Products	U.S. Food and Drug Administration
22-Dec-2020	Abivax's Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government's Clinical Trial Council	ABIVAX
22-Dec-2020	VFMCRP and ChemoCentryx provide topline results from ACCOLADE trial of avacopan in C3 glomerulopathy including improved estimated glomerular filtration rate (eGFR)	Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
22-Dec-2020	Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study	Bone Therapeutics
22-Dec-2020	Chi-Med to Present at the 39th Annual JP Morgan Healthcare Conference	Chi-Med
22-Dec-2020	Update on the recently acquired NTCD-M3 biotherapeutic clinical programme for prevention of recurrence of C. difficile infections	Destiny Pharma plc
22-Dec-2020	GLOBAL TEAM OF SCIENTISTS UNITE TO ASSESS ROLE OF T CELLS IN THE BATTLE AGAINST COVID-19 AND EVALUATE STEPS IN MANAGING AND PROTECTING AGAINST FUTURE INFECTIOUS DISEASE	Global T cell Expert Consortium
22-Dec-2020	ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ICPT	Rosen Law Firm, P.A.
22-Dec-2020	54% of UK healthcare professionals say factors other than patients’ best interests influence their medical decision-making	JMW’s Clinical Negligence team
22-Dec-2020	Polyphor receives approval to start first-in-human clinical trial of inhaled antibiotic murepavadin	Polyphor
22-Dec-2020	Bone Therapeutics finalise le recrutement et le traitement des patients dans son étude pivot de Phase III évaluant le JTA-004 dans l’arthrose du genou	Bone Therapeutics
22-Dec-2020	VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)	Vifor Pharma Group
22-Dec-2020	UKCPA Meets Demand For Critical Care Training With New Online	The UK Clinical Pharmacy Association (UKCPA)
22-Dec-2020	Transgene and BioInvent receive CTA approval for Phase 1/2a trial of oncolytic virus BT-001 in solid tumors	Transgene
22-Dec-2020	Janssen Announces European Commission Authorisation of the First Complete Long-Acting Injectable HIV Treatment in Europe	Janssen Pharmaceutical Companies of Johnson & Johnson
22-Dec-2020	GLOBAL HEALTHCARE SECTOR INVESTS OVER £1.3 MILLION TO BOOST INTERNAL COMMUNICATIONS	St George’s University Hospitals NHS Foundation Trust
22-Dec-2020	Biopsy Device Market to Witness Robust Expansion throughout the Forecast 2016 – 2026	MARKITWIRED
22-Dec-2020	Western Blotting Market to Hold a High Potential for Growth by 2021	MARKITWIRED
22-Dec-2020	Exclusive Interview with Mark DePristo, BigHat BioScience speaker at AI in Drug Discovery 2021	SMi Group